When.com Web Search

  1. Ads

    related to: methods to treat atrial fibrillation with adenosine levels of control

Search results

  1. Results From The WOW.Com Content Network
  2. Antiarrhythmic agent - Wikipedia

    en.wikipedia.org/wiki/Antiarrhythmic_agent

    Reduce ventricular rate in patients with atrial fibrillation; V Adenosine; Digoxin; Magnesium sulfate; Work by other or unknown mechanisms Contraindicated in ventricular arrhythmias; Adenosine is used to treat supraventricular tachycardias, especially in heart failure and atrial fibrillation [9]

  3. Potassium channel blocker - Wikipedia

    en.wikipedia.org/wiki/Potassium_channel_blocker

    Sotalol is indicated for the treatment of atrial or ventricular tachyarrhythmias, and AV re-entrant arrhythmias. Ibutilide is the only antiarrhythmic agent currently approved by the Food and Drug Administration for acute conversion of atrial fibrillation to sinus rhythm.

  4. Dofetilide - Wikipedia

    en.wikipedia.org/wiki/Dofetilide

    It has clinical advantages over other class III antiarrhythmics in chemical cardioversion of atrial fibrillation, and maintenance of sinus rhythm, and does not have the pulmonary or hepatotoxicity of amiodarone, however atrial fibrillation is not generally considered life-threatening, and dofetilide causes an increased rate of potentially life ...

  5. Landiolol - Wikipedia

    en.wikipedia.org/wiki/Landiolol

    Landiolol, sold under the brand name Onoact among others, is a medication used for the treatment of tachycardia, atrial fibrillation, and atrial flutter. [1] [4] It is a beta-adrenergic blocker; [4] an ultra short-acting, β1-superselective intravenous adrenergic antagonist, which decreases the heart rate effectively with less negative effect on blood pressure or myocardial contractility.

  6. XEN-D0101 - Wikipedia

    en.wikipedia.org/wiki/XEN-D0101

    XEN-D0101 is an experimental drug that was developed to treat atrial fibrillation. [when?] Xention, a biopharmaceutical company based in Cambridge, England, created XEN-D0101 along with other ion channel-modulating drugs. [1] XEN-D0101 is a selective antagonist of the voltage-gated potassium channel Kv1.5. [2]

  7. Calcium channel blocker - Wikipedia

    en.wikipedia.org/wiki/Calcium_channel_blocker

    The negative chronotropic effects of CCBs make them a commonly used class of agents in individuals with atrial fibrillation or flutter in whom control of the heart rate is generally a goal. Negative chronotropy can be beneficial when treating a variety of disease processes because lower heart rates represent lower cardiac oxygen requirements.